Dr. Lal PathLabs Limited engages in the leading diagnostic and healthcare service.
Business Segments
The company operates primarily within the healthcare diagnostic sector. This sector includes various segments such as clinical laboratory services,…
Analysis
Beloved champion
Dr. Lal PathLabs Limited sits in the top corner of our grid: excellent business, premium price; every investor already knows the story. Worth noting: the cash the business generates has lagged behind what the income statement shows.
On valuation, the picture is expensive. The owner-earnings multiple stands at 49.0×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 18% a year, against analyst forecasts of 14%. The gap between price and consensus is worth watching: demanding expectations.
Growth is moderate; the safety picture is sturdy. The company scores 13/20 on our value-creation score: creating some value.
Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202317
66
2023202420252026
All-time high
66
Jun 2026
All-time low
12
Jan 2025
Average rank
33
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
7
11
7
1
Price/Earnings
17
17
7
1
Price/Book
4
10
10
1
Dividend Yield
54
42
26
23
Value (overall)
14
9
1
1
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.